Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.67
Delayed Data
As of Dec 02
 0.00 / 0.00%
Today’s Change
1.49
Today|||52-Week Range
2.85
-20.10%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.67
Today’s open1.64
Day’s range1.64 - 1.70
Volume26,673
Average volume (3 months)41,491
Market cap$28.7M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)-36.68%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.20

Competitors

 Today’s
change
Today’s
% change
XBIOXenetic Biosciences ...+0.01+0.21%
OREXOrexigen Therapeutic...+0.08+4.40%
AXNAoxing Pharmaceutica...+0.01+2.24%
DFFNDiffusion Pharmaceut...+0.45+15.14%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts


Search for Jobs